ArticleMethods in molecular biology (Clifton, N.J.)2022
Influencing the Actin Dynamics in Plant Cells by Jasplakinolide, Chondramides, Phalloidin, Cytochalasins, and Latrunculins.
Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Chemically induced phenotype plasticity in the unicellular zygnematophyte, Penium margaritaceum.Protoplasma · 2024Article
- Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.Esophagus : official journal of the Japan Esophageal Society · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter presents an overview of the most common F-actin influencing substances, used to study actin dynamics in living plant cells for studies on morphogenesis, motility, organelle movement, apoptosis, or abiotic stress. These substances can be divided into two major subclasses-F-actin-stabilizing and F-actin-polymerizing substances like jasplakinolide and chondramides and F-actin-severing compounds like cytochalasins and latrunculins. Jasplakinolide, which may have anti-cancer activities, was originally isolated from a marine sponge and can now be synthesized and has become commercially available, which is responsible for its wide distribution as membrane-permeable F-actin-stabilizing and F-actin-polymerizing agent. Recently an acyclic derivate of jasplakinolide was isolated. Cytochalasins, derived from fungi, show an F-actin-severing function, and many derivatives are commercially available (A, B, C, D, E, H, J), also making it a widely used compound for F-actin disruption. The same can be stated for latrunculins (A, B), derived from Red Sea sponges; however the mode of action is different by binding to G-actin and inhibiting incorporation into the filament. In the case of swinholide, isolated from red algae or the cyanobacterium Nostoc, a stable complex with actin dimers is formed, resulting in severing F-actin.For influencing F-actin dynamics in plant cells, only membrane permeable drugs are useful in a broad range. We, however, introduce also the phallotoxins and synthetic derivatives thereof, as they are widely used to visualize F-actin in fixed cells. A particular uptake mechanism has been shown for hepatocytes but has also been described in siphonal giant algae. The focus is set on F-actin dynamics in plant cells where alterations in cytoplasmic streaming can be particularly well studied; moreover fluorescence methods for phalloidin- and antibody staining as well as techniques for immunoelectron microscopy are explained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.